Recent Updates
Recently added Catalysts
KYMR Positive Sentiment Score: 75/100

Kymera Therapeutics to Participate in Upcoming September Investor Conferences

Wednesday, August 28, 2024 1 min read
Key Takeaway: Kymera Therapeutics, Inc. (NASDAQ: KYMR) announced its participation in several upcoming investor conferences. The events include the Wells Fargo Healthcare Conference on September 4, the Morgan Stanley Global Healthcare Conference on September 5, and others throughout September. Live webcasts of the presentations will be available on the company’s website, demonstrating transparency and engagement with investors. This series of presentations highlights Kymera's commitment to advancing its innovative drug development initiatives.

Market Sentiment Analysis

POSITIVE FACTORS

  • Kymera Therapeutics will showcase its advancements in targeted protein degradation.
  • Participation in multiple high-profile investor conferences reflects confidence in business prospects.
  • The company is actively engaging with the investment community through live presentations.

Full Press Release Details

WATERTOWN, Mass., Aug. 28, 2024 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of small molecule medicines using targeted protein degradation (TPD), today announced that the Company will participate in fireside chats and presentations at the following upcoming investor events:
Wells Fargo 2024 Healthcare Conference in Boston, MA on September 4 at 3:00 p.m. ET;
Morgan Stanley 22nd Annual Global Healthcare Conference in New York, NY on September 5 at 3:20 p.m. ET;
H.C. Wainwright 26th Annual Global Investment Conference in New York, NY on September 9 at 8:00 a.m. ET; and
2024 Cantor Fitzgerald Global Healthcare Conference in New York, NY on September 17 at 11:30 a.m. ET.
Live webcasts of the presentations will be available under “News and Events” in the Investors section of the Company’s website at www.kymeratx.com. Replays of the webcasts will be archived and available following the events.
About Kymera Therapeutics

Tags

Targeted Protein Degradation

Frequently Asked Questions

What is Kymera Therapeutics known for?

Kymera Therapeutics specializes in a new class of small molecule medicines focusing on targeted protein degradation.

What events will Kymera participate in September 2024?

Kymera will participate in several investor events, including conferences hosted by Wells Fargo, Morgan Stanley, H.C. Wainwright, and Cantor Fitzgerald.

When will the Wells Fargo Healthcare Conference take place?

The Wells Fargo Healthcare Conference is scheduled for September 4, 2024, at 3:00 p.m. ET.

Where can I watch Kymera's presentation webcasts?

Webcasts of Kymera's presentations will be available under 'News and Events' on their website.

Will there be replays of the webcasts?

Yes, replays of the webcasts will be archived on Kymera's website following the events.

Tags: KYMR Viatris Investor Conferences Healthcare Kymera Therapeutics targeted protein degradation investor events biopharmaceutical company
Last updated: Aug 28, 2024